Seroatlas · Human Serome Atlas

GRPR

Gastrin-releasing peptide receptor

Also known as: BB2, BB2R, BRS2, GRPR_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P30550
Gene
GRPR
Ensembl
ENSG00000126010
Chromosome
X
Canonical length
384 aa
Protein class
G-protein coupled receptors, Predicted membrane proteins
Subcellular location
Plasma membrane

OverviewNCBI Gene

Gastrin-releasing peptide (GRP) regulates numerous functions of the gastrointestinal and central nervous systems, including release of gastrointestinal hormones, smooth muscle cell contraction, and epithelial cell proliferation and is a potent mitogen for neoplastic tissues. The effects of GRP are mediated through the gastrin-releasing peptide receptor. This receptor is a glycosylated, 7-transmembrane G-protein coupled receptor that activates the phospholipase C signaling pathway. The receptor is aberrantly expressed in numerous cancers such as those of the lung, colon, and prostate. An individual with autism and multiple exostoses was found to have a balanced translocation between chromosome 8 and a chromosome X breakpoint located within the gastrin-releasing peptide receptor gene. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

384 residues, UniProt reviewed canonical sequence.

>P30550|GRPR
     1  MALNDCFLLN LEVDHFMHCN ISSHSADLPV NDDWSHPGIL YVIPAVYGVI ILIGLIGNIT
    61  LIKIFCTVKS MRNVPNLFIS SLALGDLLLL ITCAPVDASR YLADRWLFGR IGCKLIPFIQ
   121  LTSVGVSVFT LTALSADRYK AIVRPMDIQA SHALMKICLK AAFIWIISML LAIPEAVFSD
   181  LHPFHEESTN QTFISCAPYP HSNELHPKIH SMASFLVFYV IPLSIISVYY YFIAKNLIQS
   241  AYNLPVEGNI HVKKQIESRK RLAKTVLVFV GLFAFCWLPN HVIYLYRSYH YSEVDTSMLH
   301  FVTSICARLL AFTNSCVNPF ALYLLSKSFR KQFNTQLLCC QPGLIIRSHS TGRSTTCMTS
   361  LKSTNPSVAT FSLINGNICH ERYV

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against GRPR can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
7
Mean surface accessibility (rSASA)
0.36
Highest tissue expression
19 nTPM

Expression across tissuesHPA

Tissue

  • pancreas: 19 nTPM
  • epididymis: 1.8 nTPM
  • breast: 1.7 nTPM
  • stomach: 1.1 nTPM
  • smooth muscle: 0.7 nTPM
  • endometrium: 0.5 nTPM

Single-cell type

  • oocytes: 14 nCPM
  • pancreatic acinar cells: 11 nCPM
  • retinal pigment epithelial cells: 4.3 nCPM
  • neuroendocrine cells: 3.6 nCPM
  • thyrotrophs: 3.4 nCPM
  • brain inhibitory neurons: 3.1 nCPM

Immune cell

  • intermediate monocyte: 0.3 nTPM
  • non-classical monocyte: 0.2 nTPM
  • classical monocyte: 0.1 nTPM
  • naive B-cell: 0.1 nTPM
  • basophil: 0 nTPM
  • eosinophil: 0 nTPM

Brain region

  • hypothalamus: 4.6 nTPM
  • spinal cord: 3.6 nTPM
  • cerebral cortex: 2.1 nTPM
  • pons: 2 nTPM
  • medulla oblongata: 1.8 nTPM
  • hippocampal formation: 1.7 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about GRPR.

Disease | ImmuneIEDB

Conditions an epitope on GRPR was assayed in.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.88
gnomAD pLI
0.22
gnomAD missense Z
0.72
DepMap mean gene effect
0
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads GRPR as an antibody target. Whether an autoantibody or antibody against GRPR could matter depends on whether native GRPR is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

GRPR is annotated at the cell surface, where native GRPR is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label GRPR as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/GRPR. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...